Navigation Links
Northwest Biotherapeutics Announces Series of Financing Arrangements
Date:6/5/2011

BETHESDA, Md., June 5, 2011 /PRNewswire/ -- Northwest Biotherapeutics (OTC.BB: NWBO) today announced that it has put in place a series of financing arrangements, including a $3 million investment already received, and access to up to $25 million of further funding on fixed, specified and favorable terms, at such times and in such amounts as the Company chooses.  This series of financing arrangements will provide a strong financial foundation for completion of the Company's ongoing 240-patient clinical trial of DCVax®-L for the treatment of Glioblastoma multiforme (GBM) brain cancer, and will also provide for certain other programs in the Company's near term pipeline.

(Logo:  http://photos.prnewswire.com/prnh/20110329/SF73084LOGO)

As the first component of the overall financing arrangements, the initial $3 million investment has been provided by a multi-billion dollar institutional investment fund based in Minnesota.  The investment is structured as a convertible note with warrants.  The note is not convertible until maturity, 18 months after closing, and is only convertible into unregistered restricted stock at that time.  The conversion price of the note is a fixed, specified price per share, at a three percent (3%) discount from the market price at the time of the note agreement (the volume weighted average price over the 10 trading days ending on the May 31st closing date), and the warrant coverage is one hundred percent without any cashless exercise provision.

As such, this $3 million investment reflects a long-term interest in the Company on the part of the investor, and will provide for the continued acceleration of the Company's GBM brain cancer clinical trial while the arrangements for the $25 million follow-on facility are being implemented.

"We are pleased to receive strong support and long-term interest from a major institution
'/>"/>

SOURCE Northwest Biotherapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Northwestern chemists take gold, mass-produce Beijing Olympic logo
2. Northwest Secures US$1.0 Million Debt Financing
3. Northwest Secures US$1.65 Million Debt Financing
4. Northwest Biotherapeutics Settles Class Action Complaint, and SEC Investigation Closed Without Action
5. Pacific Northwest National Laboratories Becomes a GeneGo Center of Excellence
6. Northwest Biotherapeutics Secures $700,000 Equity Financing
7. Sirius Genomics to Present at Invest Northwest Conference
8. Oncothyreon to present at Invest Northwest 2009
9. Cell Therapeutics, Inc. (CTI) to Present at 8th Annual WBBA Invest Northwest Conference
10. Cell Therapeutics Presents Corporate Highlights at Invest Northwest Conference
11. Dendreon Corporation CEO Mitchell H. Gold, M.D. Named Ernst & Young Entrepreneur of the Year(R) 2009 Award Finalist in the Pacific Northwest
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... May 24, 2013 This market ... on kinase profiling carried out in May 2013. ... the breakdown of the responses for each question, ... (2015). It also highlights some interesting differences, particularly ... Two bottom-up models were developed to estimate the ...
(Date:5/24/2013)... (PRWEB) May 24, 2013 Vestiage, ... lifestyle company focused on science-based research and development, ... anti-aging cosmeceuticals and nutraceuticals, announced today that it ... States for the sale of Reluma Skin Illuminating ... packet and application by sending an email to ...
(Date:5/23/2013)... Arbor, Mich. Every day, their baby stopped breathing, ... to his lungs. April and Bryan Gionfriddo watched helplessly, ... , "Quite a few doctors said he had a ... April Gionfriddo, about her now 20-month-old son, Kaiba. "At ... we would take it and run with it." , ...
(Date:5/23/2013)... May 23, 2013 Can economic incentives ... work motivate members of the public to increase their ... Johns Hopkins Carey Business School Assistant Professor ... Pointing to a large body of recent research that ... May 24, 2013, issue of Science that the World ...
Breaking Biology Technology:Kinase Market Profiling - In House & Outsourced Trends 2015 Forecast in New Research Report at ReportsnReports.com 2Kinase Market Profiling - In House & Outsourced Trends 2015 Forecast in New Research Report at ReportsnReports.com 3Kinase Market Profiling - In House & Outsourced Trends 2015 Forecast in New Research Report at ReportsnReports.com 4Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 2Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 3Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 4Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 5Baby's life saved with groundbreaking 3-D printed device that restored his breathing 2Baby's life saved with groundbreaking 3-D printed device that restored his breathing 3Offering Economic Incentives to Attract Blood Donations Should Be Encouraged, Research Team writes in Science 2Offering Economic Incentives to Attract Blood Donations Should Be Encouraged, Research Team writes in Science 3
... developed a new test to detect the levels of vitamin ... simpler diagnosis that could help to avoid the potentially fatal ... today, 23 June 2011, in IOP Publishing,s Journal of ... breath test to more accurately measure vitamin B12. ...
... 2011 Clinical Research Management, (ClinicalRM) a full-service ... applied research, clinical trials, and regulatory support, announced ... $97MM research support contract titled Support for Military ... performed at the Walter Reed Army Institute of ...
... 22, 2011 CMC Biologics today announced that it ... steel biopharmaceutical production facility at its Bothell campus and ... new logo and a compelling tagline. These recent changes ... (Logo:   http://photos.prnewswire.com/prnh/20110502/SF93356LOGO ) The ...
Cached Biology Technology:A breath of fresh air for detecting vitamin B12 deficiency 2ClinicalRM (formerly CRM) Awarded $97MM U.S. Army Contract to Support Military Clinical Research for the Warfighter 2CMC Biologics Expands Its Production Facility and Rebrands Its Corporate Identity 2
(Date:5/22/2013)... novel technique that can detect molecular variants in chemical ... of the most important, though time-consuming, processes in analytical ... Nature , post-doctoral researcher David Patterson, Professor of ... Center for Free-Electron Laser Science (CFEL) in Hamburg, Germany ... to identify molecular variants apart, and to determine how ...
(Date:5/22/2013)... environmental and human health effects from disposal of ... led scientists to recommend stronger government policies to ... battery materials. That,s the conclusion of a new ... & Technology . , Oladele A. Ogunseitan and ... mainstays for powering everything from smart phones to ...
(Date:5/22/2013)... Calif., May 22, 2013 Early screening for prostate ... pregnancy testing is for women, thanks to UC Irvine ... American Chemical Society . , After more than a ... way to clearly identify clinically usable markers for prostate ... detected far sooner, with greater accuracy and at dramatically ...
Breaking Biology News(10 mins):Detecting mirror molecules 2Detecting mirror molecules 3UCI chemists devise inexpensive, accurate way to detect prostate cancer 2UCI chemists devise inexpensive, accurate way to detect prostate cancer 3
... sarcoma herpesvirus (KSHV) is a human tumor virus and ... lymphoma (PEL). PELs are aggressive lymphomas with reported median ... at the University of Helsinki have discovered that activation ... modality for KSHV-infected lymphomas. , The findings by the ...
... epidemic in China has lessons to teach hospitals on ... according to new research appearing in the April 15 ... Hospitals were epicenters of SARS transmission in Guangzhou province ... severe outbreaks, the researchers looked at environmental and administrative ...
... cytochrome c oxidase (CcO) is the ultimate enzyme responsible ... people. It is also a crucial component of the ... such impressive credentials, you might expect that scientists would ... they don't, according to James P. Collman, professor emeritus ...
Cached Biology News:Finnish scientists discovered a new approach to treat virus-induced lymphomas 2Study identifies risk factors for spread of respiratory infections in hospitals 2Researchers create artificial enzyme that mimics the body's internal engine 2Researchers create artificial enzyme that mimics the body's internal engine 3
... phase reagent for Virus ... & unique water insoluble ... detergents and chaotropes; Engineered ... non-envelop viruses while preserving ...
Mouse monoclonal [N7519] to NR0B2 ( Abpromise for all tested applications). Antigen: E.coli expressed recombinant full length protein (Human) NR0B2 Entrez Gene ID: 8431 Swiss Protein ID: ...
Ubiquitin Related I Sampler Kit 10 mu g each...
Rabbit polyclonal to BCA1 ( Abpromise for all tested applications). Antigen: Generated using E.coli expressed mouse BCA1. Entrez GeneID: 10563 SWISS Protein ID: O43927...
Biology Products: